Burning Rock Biotech Ltd ADR BNR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $9.61
- Day Range
- $9.56–10.10
- 52-Week Range
- $4.52–41.72
- Bid/Ask
- $9.86 / $10.13
- Shares Outstanding
- 10.55M
- Market Cap
- $105.41M
- Volume/Avg
- 4,132 / 24,590
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.40
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- —
- Total Number of Employees
- 667
- Website
- https://www.brbiotech.com
Valuation
|
Metric
|
BNR
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.36 |
Price/Sales | 1.40 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BNR
|
|---|---|
Quick Ratio | 2.71 |
Current Ratio | 3.05 |
Interest Coverage | — |
Quick Ratio
BNR
Profitability
|
Metric
|
BNR
|
|---|---|
Return on Assets (Normalized) | −7.23% |
Return on Equity (Normalized) | −10.84% |
Return on Invested Capital (Normalized) | −11.20% |
Return on Assets
BNR
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|K#y#$#> | LOCK|%v | $199B | |||
| Danaher Corp
DHR
| LOCK|WGQn?Nn | LOCK|fn? | $142B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|Dqsb@tjX | LOCK|&r | $44B | |||
| Agilent Technologies Inc
A
| LOCK|>XYJqSC | LOCK|J! | $38B | |||
| Waters Corp
WAT
| LOCK|#x#%Q>v | LOCK|@M> | $37B | |||
| IQVIA Holdings Inc
IQV
| LOCK|Sh<q?>g | LOCK|fNX?n | $35B | |||
| Illumina Inc
ILMN
| LOCK|R$jQ#w | LOCK|P<Bh | $28B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|w%%yh#Z> | LOCK|^FC^ | $27B | |||
| Quest Diagnostics Inc
DGX
| LOCK|GB?!dtW | LOCK|s#XF^ | $22B | |||
| Labcorp Holdings Inc
LH
| LOCK|#@@Mcwl> | LOCK|^>b> | $22B |
United States